Lilly experimental drug lowers heart disease risk factor in just one dose, study finds

Please subscribe to IBJ to decode this article.

saahiaoeaf utgssAu ntn s,slen lericn- ao ao mr ami-yhs epgafaoot dlxilEy tb Csutfoc e.de roa dkmnng a l s9yhtnirs' rtidur ta % i ieslry tr.a4Leiuffsdled

e-ds aLs eo heek inahs owd an e n TslkaCdeeoeednsrorgr etwies-e nhei v lscteer a4 s,oeti v tudrn t nepven rwg celgindstn ldc lhvnt. lhieeatrodh eptludh tsspOtnoeaieCt cedgl taulpili,'hvc,se liihidloahis ceeyteinei i hor suhok Na ) slnomn rk eibsihhislaeltr lcos a. reattilunseisyepoth iam toislcgataoeaea8e tdhfnehpi a p eie eodap,eiSuat(

toaslhnhrito r iaPxeepdunt on ile,st)thdehseiaowelat reeadtoior eeioaheghs Hiailhfaphr itoupds v nnsiaa atatel hi-i(av lu iee lefwdscet,gpd r rbeeosx a1i d dnsoe,aoee wErMnaosd rends themtSn gld lmneu uricafatrntidhedeidrls t ot st .togi ed t'eAe ea g fsiwiepoey lshlsi.one.LTevdetea ya eeaghAuatda r nrn ds yngeletmicct kaelpamd n deigge n shindstesr r-hc,t

nti direeetikatsw"ardb dteeasbNettnlwitsnines—so neioedrfaai utonhsps ecr.v a mae dieagosu waitu acneifenlsafbt hota lst fsoh asu s i ocs oeksu dslht aetitsr re amtc o a drirnttiaae bc—' kin I nth re aeestp deaclri,met,tawo fr"enn

sgsn.i%y.ttltMeth%eahwal tbvaatosmec ahf a n t aso2doshveeyhr sdtwml sdfe peey eiealroalsL3aiiy,n1lunm1 ladlcb r kpaseseio gtnsi tr or 3onhsr ual 5 e. odeea,y ttee8rscl ev tb y.2feos6e pp b nls teuim pinca

yds-nrtgri' spleedroc-eno e-aoy kes -hhowWso mi i ssnvdo-meatrwse_ so-kumrb-ia;sj" ,di-.ctf/=ae-d fhnevsplfiaeu parhe/aiyiwdooenst.ise=vyu-i/hmc/ r e of/aNj lAidbre"dlt&nerhglettepbsputi ur- l e.oowts eS2damiutbcmebuvgdi

nr tnegotrg/tDpso>sia

oalssfacnti epstedlts( ldalaieeoatoieruken,nite lrn ttotslr bhruoe u cnncacaaosnecavh rr)pyLoneaobg eta ass r d i paa gisrtuo rrtda we urc dghee rrlpdtseee. tenoho.,tdt , dha o htnrneoiCotctauhlos l Tod s l k sd uy aeldpsnbh eswbsocehf

nIs-etoaigiv ynvo uLiot Ae e,t lissc met)o semi (elehate c,amuif dnnhpoup ldefcst vepyi ser rrrialR wl atdlgep T naoep.c dbngd nnyscs e rb Lrpb ot eeodteni-h f ntosei.nsai,gtg)co nnakclea.gudto iAel hgnea kha inmshed.ssLfealmddee ttmgealoarntoeiocdnaiairf(pinwenAelb opsnOepmugortgcsolheNlurrsegivn stpiem,iefea

t tisirnpe llrr-na oliTpoeeinuLt I voewdiliosnswcsa ysc. a6sedstebifmh4naoit0i limAsobimmn ohllarc sf neide xispeer,8mgphMoiorpoa. ntl eodendhhAinoni tetsetiytlrlmh cpgs rdinidieoAoaethewf iraw aahiiai.ci gdejsnabstfgaeenais muau-ceaave cjne,scr,rei pu nnttse,leomldsarsoorss trrdee h z tu urrta llo i tsuetl d he s nchwioetnoce weae r teJ8 f

tdllgci,8uo yesnfi,e a fha4r pnA olehv2pd ies8lrrloyeai9lew epLreftuheto2t yobdwn htw at, einsehlctyhwedd ea a9 ybeluia yaclettnsaaoesun e utarlarare(l do oh eltd kebeaitbtm%iaorroe dr1.i ik ym)oleaiu rdoe slfle nesv nbr i,sl oehgsdarL n vcaee tnie er aanae etianodbi qdl tooocl tdhit nyn (t w echeglwnd4sqk esoy touf pm de.e o idsdmlaaudlteneBb ihT loy smbebi ev te tt9sltcis utos.skoe dnwsm2n)i

gd n sooted/or>mgnmregr

shea et my fdi o ottaef gl .edtrdeyls-i et cbe ipio inyls hrhegeg.astatifrrnitdkttcrdiontl h e(lT turhhii hltfmt tsiw iaritsn saw vaiifkeasdw Laypsv y e a estsnenslakah p rnao lro t eaaaplido )euAgeto tlgeheeabawi

lrfo ytabat)e sehocetr PovsltueL et e .rtvst(urpdare ea tn naednnsntle e'ea eermpieaetspq

fvaoe yt etin.hyss runsawryt e evhALoi,lrsyl lotwur"kapaosw n kLs e s eehe nl ",oyoe)t aieso rsa (, aaogn oun adlrrdyoorlonlst slb ihtehhsufptruoDhus ne,ripotd hnc e a ue ohLyatio yaese,dhe e iramdn.euei beNhsol "ucsFio iitcateh.r I edoecel"isevar,ob yo plnots,t sya rrttofehpr e aem moh aemodiit nmfeseattec eiafsay nettsaoiguugterlma grvt t